Most people have accepted the role of reducing insulin resistance in order to improve fertility and reduce miscarriage in women with PCOS. The question that often comes up is what is the most strategy to achieve this goal. True there are many dietary and lifestyle modifications that can improve insulin sensitivity. The problem is that each person needs a different combination of recommendations tailored to their unique situation. That’s why having a simple and well researched medication to prescribe is such a bonus. Metformin meets these needs.
Not only has metformin been shown to improve fertility; it has also been linked to a reduced risk of miscarriage as well. Now there is a growing body of evidence that metformin can reduce the risk of various cancers.
Many studies have shown the type II diabetes—the most severe form of insulin resistance—is associated with elevated risks of various types of cancer. So it has long been hoped that the types of medications that can reduce insulin resistance should also reduce cancer risks. Better still; the data that has emerged with the use of metformin has also been associated with a reduced risk of endometrial (uterian) cancer and breast cancer.
So if you’ve got insulin resistance and want to become pregnant, there is even more compelling reasons to consider metformin as part of your treatment regimen.